CLINICAL_TRIALS
trial_result
· 2012-03-28
Clinical Trial Update: Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012
Summary
Pfizer conducted a retrospective observational update to report 5-year survival of subjects who participated in Axitinib trial A4061012; results were posted in …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Status: COMPLETED | Results posted: 2012-03-28